1. Saho T, Onishi H. Evaluation of the impact of carotid artery bifurcation angle on hemodynamics by use of computational fluid dynamics: a simulation and volunteer study. Radiol Phys Technol 2016;9:277-85.

2. Orekhov AN, Melnichenko AA, Sobenin IA. Approach to reduction of blood atherogenicity. Oxid Med Cell Longev 2014;2014:738679.

3. Nus M, Mallat Z. Immune-mediated mechanisms of atherosclerosis and implications for the clinic. Expert Rev Clin Immunol 2016;12:1217-37.

4. Sobenin IA, Galitsyna EV, Grechko AV, Orekhov AN. Small dense and desialylated low density lipoprotein in diabetic patients. Vessel Plus 2017;1:29-37.

5. Wu GC, Leng RX, Lu Q, Fan YG, Wang DG, Ye DQ. Subclinical atherosclerosis in patients with inflammatory Bowel diseases: a systematic review and meta-analysis. Angiology 2017;68:447-61.

6. Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, Coresh J, Selvin E, Kao WH. Genetics of plasma soluble receptor for advanced glycation end-products and cardiovascular outcomes in a community-based population: results from the atherosclerosis risk in communities study. PLoS One 2015;10:e0128452.

7. Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol 2016;8:1-23.

8. Pokharel Y, Sun W, Polfus LM, Folsom AR, Heiss G, Sharrett AR, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: the Atherosclerosis Risk In Communities Study. Atherosclerosis 2015;241:641-8.

9. Yu B, Li AH, Muzny D, Veeraraghavan N, de Vries PS, Bis JC, Musani SK, Alexander D, Morrison AC, Franco OH, Uitterlinden A, Hofman A, Dehghan A, Wilson JG, Psaty BM, Gibbs R, Wei P, Boerwinkle E. Association of rare loss-of-function alleles in HAL, serum histidine: levels and incident coronary heart disease. Circ Cardiovasc Genet 2015;8:351-5.

10. Inanloorahatloo K, Zand Parsa AF, Huse K, Rasooli P, Davaran S, Platzer M, Fan JB, Amini S, Steemers F, Elahi E. Mutation in CYP27A1 identified in family with coronary artery disease. Eur J Med Genet 2013;56:655-60.

11. Han CB, Ma JM, Xin Y, Mao XY, Zhao YJ, Wu DY, Zhang SM, Zhang YK. Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance. World J Gastroenterol 2005;11:31-5.

12. Zhelankin A, Khasanova Z, Barinova L, Sazonova M, Postnov A, Sobenin I. 1A.06: mitochondrial DNA haplogroup H is associated with subclinical carotid atherosclerosis in russian population. J Hypertens 2015;33:e2.

13. Solano A, Roig M, Vives-Bauza C, Hernandez-Pe-a J, Garcia-Arumi E, Playan A, Lopez-Perez MJ, Andreu AL, Montoya J. Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene. Ann Neurol 2003;54:527-30.

14. Jeppesen TD, Schwartz M, Hansen K, Danielsen ER, Wibrand F, Vissing J. Late onset of stroke-like episode associated with a 3256C-->T point mutation of mitochondrial DNA. J Neurol Sci 2003;214:17-20.

15. Horváth R, Scharfe C, Hoeltzenbein M, Do BH, Schröder C, Warzok R, Vogelgesang S, Lochmüller H, Müller-Höcker J, Gerbitz KD, Oefner PJ, Jaksch M. Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. J Med Genet 2002;39:812-6.

16. Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, Orekhov A. Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.

17. Sazonova MA, Sinyov VV, Barinova VA, Ryzhkova AI, Zhelankin AV, Postnov AY, Sobenin IA, Bobryshev YV, Orekhov AN. Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta. Biomed Res Int 2015;2015:825468.

18. Sazonova MA, Chicheva MM, Zhelankin AV, Sobenin IA, Bobryshev YV, Orekhov AN. Association of mutations in the mitochondrial genome with the subclinical carotid atherosclerosis in women. Exp Mol Pathol 2015;99:25-32.

19. Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, Postnov AY, Nurbaev SD, Bobryshev YV, Orekhov AN. Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 2012;7:e46573.

20. Sobenin IA, Surnin SA, Karagodin VP, Miasoedova VA, Kirichenko TV, Chuprakova OV, Kozhevnikova IuA, Kovalevskaia LO, Orekhov AN. Variability of intima-media thickness of the common carotid arteries in Moscow city population without clinical symptoms of atherosclerosis. Ter Arkh 2011;83:58-62. (in Russian)

21. Sobenin IA, Myasoedova VA, Anisimova EV, Pavlova XN, Möhlenkamp S, Schmermund A, Seibel R, Berenbein S, Lehmann N, Moebus S, Jöckel K, Orekhov AN, Erbel R. Blood serum atherogenicity and coronary artery calcification. Curr Pharm Des 2014;20:5884-8.

22. Myasoedova VA, Kirichenko TV, Melnichenko AA, Orekhova VA, Ravani A, Poggio P, Sobenin IA, Bobryshev YV, Orekhov AN. Anti-atherosclerotic effects of a phytoestrogen-rich herbal preparation in postmenopausal women. Int J Mol Sci 2016;17:E1318.

23. Kirichenko TV, Myasoedova VA, Orekhova VA, Ravani AL, Nikitina NA, Grechko AV, Sobenin IA, Orekhov AN. Phytoestrogen-rich natural preparation for treatment of climacteric syndrome and atherosclerosis prevention in perimenopausal women. Phytother Res 2017;31:1209-14.

24. Aguilera I, Dratva J, Caviezel S, Burdet L, de Groot E, Ducret-Stich RE, Eeftens M, Keidel D, Meier R, Perez L, Rothe T, Schaffner E, Schmit-Trucksäss A, Tsai MY, Schindler C, Künzli N, Probst-Hensch N. Particulate matter and subclinical atherosclerosis: associations between different particle sizes and sources with carotid intima-media thickness in the SAPALDIA study. Environ Health Perspect 2016;124:1700-06.

25. Liu X, Lian H, Ruan Y, Liang R, Zhao X, Routledge M, Fan Z. Association of exposure to particular matter and carotid intima-media thickness: a systematic review and meta-analysis. Int J Environ Res Public Health 2015;12:12924-40.

26. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012;34:290-6.

27. Amato M, Veglia F, de Faire U, Giral P, Rauramaa R, Smit AJ, Kurl S, Ravani A, Frigerio B, Sansaro D, Bonomi A, Tedesco CC, Castelnuovo S, Mannarino E, Humphries SE, Hamsten A, Tremoli E, Baldassarre D; IMPROVE study group. Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification. Atherosclerosis 2017;263:412-9.

28. Sobenin IA, Zhelankin AV, Mitrofanov KY, Sinyov VV, Sazonova MA, Postnov AY, Orekhov AN. Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases. Curr Pharm Des 2015;21:1158-63.

29. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning : a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1982.

30. Zhang XX, Li MR, Cao Y, Zhang RW, Zhang Y, Li F, Xi HL, Xu XY. Dynamics of genotypic mutations of the hepatitis B virus associated with long-term entecavir treatment determined with ultradeep pyrosequencing: a retrospective observational study. Medicine (Baltimore) 2016;95:e2614.

31. Harrington CT, Lin EI, Olson MT, Eshleman JR. Fundamentals of pyrosequencing. Arch Pathol Lab Med 2013;137:1296-303.

32. Kreutz M, Schock G, Kaiser J, Hochstein N, Peist R. PyroMark® instruments, chemistry, and software for Pyrosequencing® analysis. Methods Mol Biol 2015;1315:17-27.

33. Rajatileka S, Luyt K, Williams M, Harding D, Odd D, Molnár E, Váradi A. Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing. BMC Genet 2014;15:80.

34. Simou M, Kouskouni E, Vitoratos N, Economou E, Creatsas G. Polymorphisms of platelet glycoprotein receptors and cell adhesion molecules in fetuses with fetal growth restriction and their mothers as detected with pyrosequencing. In Vivo 2017;31:243-9.

35. Mahmood U, Imran M, Naik SI, Cheema HA, Saeed A, Arshad M, Mahmood S. Detection of common mutations in the GALT gene through ARMS. Gene 2012;509:291-4.

36. Fondevila M, Børsting C, Phillips C, de la Puente M, Consortium EN, Carracedo A, Morling N, Lareu MV. Forensic SNP genotyping with SNaPshot: technical considerations for the development and optimization of multiplexed SNP assays. Forensic Sci Rev 2017;29:57-76.

37. Salimullah M, Hamano K, Tachibana M, Inoue K, Nishigaki K. Efficient SNP analysis enabled by joint application of the muTGGE and heteroduplex methods. Cell Mol Biol Lett 2005;10:237-45.

38. Sazonova MA, Shkurat TP, Demakova NA, Zhelankin AV, Barinova VA, Sobenin IA, Orekhov AN. Mitochondrial genome sequencing in atherosclerosis: what's next? Curr Pharm Des 2016;22:390-6.

39. Ladouceur M, Zheng HF, Greenwood CM, Richards JB. Empirical power of very rare variants for common traits and disease: results from sanger sequencing 1998 individuals. Eur J Hum Genet 2013;21:1027-30.

40. Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. BMC Infect Dis 2016;16:458.

41. Yeo MK, Jung MK, Lee SY, Lee YM, Hur GM, Kim JM. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing. J Clin Pathol 2017;70:260-5.

42. Mohamed S, Bourliere M, Benali S, Oules V, Castellani P, Khiri H, Camus C, Penaranda G, Chiche L, Gonzalez D, Sayada C, Olive D, Halfon P. Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure. J Clin Virol 2016;78:36-43.

43. Pu D, Mao C, Cui L, Shi Z, Xiao P. Pyrosequencing with di-base addition for single nucleotide polymorphism genotyping. Anal Bioanal Chem 2016;408:3113-23.

44. Kuscu C, Kuscu C. Pyrosequencing analysis for breast cancer DNA methylome. Methods Mol Biol 2016;1406:89-104.

45. Matsunaga H, Tanaka Y, Tanaka M, Gong JS, Zhang J, Nomiyama T, Ogawa O, Ogihara T, Yamada Y, Yagi K, Kawamori R. Antiatherogenic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care 2001;24:500-3.

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us


All published articles are preserved here permanently:


All published articles are preserved here permanently: